Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Name: Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma
Published: 2025
License: Public Domain

Children's Oncology Group · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

childhood astrocytoma, childhood diffuse intrinsic pontine glioma, childhood diffuse midline glioma, childhood glioblastoma, childhood malignant glioma, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Related documents